| Durable Remissions with Ivosidenib in IDH1-Mutated Relapsed or Refractory AML CD DiNardo, EM Stein, S de Botton, GJ Roboz, JK Altman, AS Mims, ... New England Journal of Medicine 378 (25), 2386-2398, 2018 | 1352 | 2018 |
| CPX-351 (cytarabine and daunorubicin) liposome for injection versus conventional cytarabine plus daunorubicin in older patients with newly diagnosed secondary acute myeloid … JE Lancet, GL Uy, JE Cortes, LF Newell, TL Lin, EK Ritchie, RK Stuart, ... Journal of Clinical Oncology 36 (26), 2684, 2018 | 882 | 2018 |
| TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes JS Welch, AA Petti, CA Miller, CC Fronick, M O’Laughlin, RS Fulton, ... New England Journal of Medicine 375 (21), 2023-2036, 2016 | 813 | 2016 |
| Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100 B Nervi, P Ramirez, MP Rettig, GL Uy, MS Holt, JK Ritchey, JL Prior, ... Blood, The Journal of the American Society of Hematology 113 (24), 6206-6214, 2009 | 578 | 2009 |
| A phase 1/2 study of chemosensitization with the CXCR4 antagonist plerixafor in relapsed or refractory acute myeloid leukemia GL Uy, MP Rettig, IH Motabi, K McFarland, KM Trinkaus, LM Hladnik, ... Blood, The Journal of the American Society of Hematology 119 (17), 3917-3924, 2012 | 427 | 2012 |
| Impact of mobilization and remobilization strategies on achieving sufficient stem cell yields for autologous transplantation I Pusic, SY Jiang, S Landua, GL Uy, MP Rettig, AF Cashen, P Westervelt, ... Biology of Blood and Marrow Transplantation 14 (9), 1045-1056, 2008 | 424 | 2008 |
| Ivosidenib induces deep durable remissions in patients with newly diagnosed IDH1-mutant acute myeloid leukemia GJ Roboz, CD DiNardo, EM Stein, S de Botton, AS Mims, GT Prince, ... Blood, The Journal of the American Society of Hematology 135 (7), 463-471, 2020 | 320 | 2020 |
| Localization of human Cdc25C is regulated both by nuclear export and 14-3-3 protein binding PR Graves, CM Lovly, GL Uy, H Piwnica-Worms Oncogene 20 (15), 1839-1851, 2001 | 277 | 2001 |
| Genomic analysis of germ line and somatic variants in familial myelodysplasia/acute myeloid leukemia JE Churpek, K Pyrtel, KL Kanchi, J Shao, D Koboldt, CA Miller, D Shen, ... Blood, The Journal of the American Society of Hematology 126 (22), 2484-2490, 2015 | 263 | 2015 |
| The Drosophila grapes gene is related to checkpoint gene chk1/rad27 and is required for late syncytial division fidelity P Fogarty, SD Campbell, R Abu-Shumays, B de Saint Phalle, RY Kristina, ... Current Biology 7 (6), 418-426, 1997 | 243 | 1997 |
| Flotetuzumab as salvage immunotherapy for refractory acute myeloid leukemia GL Uy, I Aldoss, MC Foster, PH Sayre, MJ Wieduwilt, AS Advani, ... Blood, The Journal of the American Society of Hematology 137 (6), 751-762, 2021 | 241 | 2021 |
| Final results of a phase III randomized trial of CPX-351 versus 7+ 3 in older patients with newly diagnosed high risk (secondary) AML. JE Lancet, GL Uy, JE Cortes, LF Newell, TL Lin, EK Ritchie, RK Stuart, ... Journal of Clinical Oncology 34 (15_suppl), 7000-7000, 2016 | 222 | 2016 |
| BIO5192, a small molecule inhibitor of VLA-4, mobilizes hematopoietic stem and progenitor cells P Ramirez, MP Rettig, GL Uy, E Deych, MS Holt, JK Ritchey, JF DiPersio Blood, The Journal of the American Society of Hematology 114 (7), 1340-1343, 2009 | 197 | 2009 |
| Genome sequencing as an alternative to cytogenetic analysis in myeloid cancers EJ Duncavage, MC Schroeder, M O’Laughlin, R Wilson, S MacMillan, ... New England Journal of Medicine 384 (10), 924-935, 2021 | 190 | 2021 |
| Targeting CD123 in acute myeloid leukemia using a T-cell–directed dual-affinity retargeting platform M Al-Hussaini, MP Rettig, JK Ritchey, D Karpova, GL Uy, LG Eissenberg, ... Blood, The Journal of the American Society of Hematology 127 (1), 122-131, 2016 | 189 | 2016 |
| Maintenance therapy with decitabine after allogeneic stem cell transplantation for acute myelogenous leukemia and myelodysplastic syndrome I Pusic, J Choi, MA Fiala, F Gao, M Holt, AF Cashen, R Vij, CN Abboud, ... Biology of Blood and Marrow Transplantation 21 (10), 1761-1769, 2015 | 165 | 2015 |
| US intergroup study of chemotherapy plus dasatinib and allogeneic stem cell transplant in Philadelphia chromosome positive ALL F Ravandi, M Othus, SM O'Brien, SJ Forman, CS Ha, JYC Wong, ... Blood advances 1 (3), 250-259, 2016 | 156 | 2016 |
| Severe cytokine-release syndrome after T cell–replete peripheral blood haploidentical donor transplantation is associated with poor survival and anti–IL-6 therapy is safe and … R Abboud, J Keller, M Slade, JF DiPersio, P Westervelt, MP Rettig, ... Biology of Blood and Marrow Transplantation 22 (10), 1851-1860, 2016 | 154 | 2016 |
| A phase 2 study of high-dose lenalidomide as initial therapy for older patients with acute myeloid leukemia TA Fehniger, GL Uy, K Trinkaus, AD Nelson, J Demland, CN Abboud, ... Blood, The Journal of the American Society of Hematology 117 (6), 1828-1833, 2011 | 149 | 2011 |
| Acute lymphoblastic leukemia, version 2.2015 JC Alvarnas, PA Brown, P Aoun, KK Ballen, SK Barta, U Borate, ... Journal of The national comprehensive cancer network 13 (10), 1240-1279, 2015 | 136 | 2015 |
